These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 23770334

  • 21. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F, Heffernan C, Meurice F, Ota MOC, Vetter V, Casabona G.
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [Abstract] [Full Text] [Related]

  • 22. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G, Gareca M, Kincaid H, Knouse MC.
    J Travel Med; 2015 Jul; 22(6):396-402. PubMed ID: 26412393
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
    Pang H, Zhou Y, Zhao W, Jiang Q.
    Int J Environ Res Public Health; 2018 Sep 23; 15(10):. PubMed ID: 30249033
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L.
    MMWR Recomm Rep; 1998 May 22; 47(RR-8):1-57. PubMed ID: 9639369
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age.
    Saffar H, Mousavi SJ, Saffar H, Parsaei MR, Ghorbani GR, Saffar MJ.
    BMC Immunol; 2022 Jan 16; 23(1):2. PubMed ID: 35034609
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V.
    Cochrane Database Syst Rev; 2020 Apr 20; 4(4):CD004407. PubMed ID: 32309885
    [Abstract] [Full Text] [Related]

  • 34. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C, Mankertz A.
    PLoS One; 2012 Apr 20; 7(8):e42867. PubMed ID: 22880124
    [Abstract] [Full Text] [Related]

  • 35. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China.
    Sun X, Tang F, Hu Y, Deng X, Wang Z, Zhou M, Liu Y.
    Hum Vaccin Immunother; 2020 Jul 02; 16(7):1738-1742. PubMed ID: 31977281
    [Abstract] [Full Text] [Related]

  • 36. Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium.
    Leuridan E, Maertens K, Wautier M, Hutse V, Theeten H.
    Eur J Pediatr; 2015 Jul 02; 174(7):925-32. PubMed ID: 25579232
    [Abstract] [Full Text] [Related]

  • 37. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 38. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, Takahashi M, Aoyagi T, Hatta M, Gu Y, Yano H, Weber DJ, Kaku M.
    Tohoku J Exp Med; 2014 Oct 25; 234(2):111-6. PubMed ID: 25224029
    [Abstract] [Full Text] [Related]

  • 39. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A.
    Arch Iran Med; 2013 Jan 25; 16(1):38-41. PubMed ID: 23273235
    [Abstract] [Full Text] [Related]

  • 40. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
    Karadeniz A, Akduman Alaşehir E.
    J Infect Public Health; 2020 Apr 25; 13(4):480-484. PubMed ID: 32113699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.